Availability of anti-tuberculosis drugs in Europe Source: Eur Respir J 2012; 40: 500-503 Year: 2012
Availability of drug susceptibility testing to new/re-purposed anti-tuberculosis drugs: a TBnet study Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021
From policy to practice in Europe: a TBNET survey on the delivery of LTBI screening and treatment amongst migrants Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018
Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe Source: Eur Respir J, 58 (3) 2101196; 10.1183/13993003.01196-2021 Year: 2021
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Source: Eur Respir J 2012; 39: 802-804 Year: 2012
Availability of PCR for second-line drugs in Europe Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment Year: 2016
Smoking cessation services in Russia: do we meet the demand? Results from Russian tobacco control policy evaluation survey Source: International Congress 2019 – Old and new approaches to support tobacco cessation Year: 2019
New anti-tuberculosis drugs and regimens: 2015 update Source: ERJ Open Res 2015; 1: 00010-2015 Year: 2015
Improving adherence in TB patients with alcohol and drug dependence through Sputnik initiative in Tomsk, Russia Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008
COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
MDR-TB in Eastern Europe: new public health interventions Source: International Congress 2016 – The problem of multidrug-resistant tuberculosis Year: 2016
Respiratory medicines for children: current evidence, unlicensed use and research priorities Source: Eur Respir J 2010; 35: 247-265 Year: 2010
Shadow reporting on compliance to tobacco advertisement bans at points of sale in Turkey Source: Annual Congress 2013 –E-cigarettes, shisha, the tobacco industry and public health Year: 2013
Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice Source: Eur Respir J 2016; 48: 1571-1581 Year: 2016
Raising cigarette prices decreases consumption without increase in smuggling: A study from Iran Source: Annual Congress 2013 –E-cigarettes, shisha, the tobacco industry and public health Year: 2013
Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment Source: International Congress 2015 – Screening strategies in TB Year: 2015
Oxygen prescription and administration audit at a UK teaching hospital: compliance with British thoracic society (BTS) guidelines and the impact of electronic prescribing Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009
Knowledge of tuberculosis-treatment prescription of health workers: a systematic review Source: Eur Respir J 2012; 39: 1248-1255 Year: 2012
Prevalence of switching from brand to generic asthma medications Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015